{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:20:34Z","timestamp":1792592434614,"version":"4.5.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1038\/hr.2015.106","type":"journal-article","created":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T06:32:35Z","timestamp":1443681155000},"page":"804-806","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Multifunctional L\/N- and L\/T-type calcium channel blockers for kidney protection"],"prefix":"10.1038","volume":"38","author":[{"given":"Masanori","family":"Abe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayoshi","family":"Soma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,1]]},"reference":[{"key":"BFhr2015106_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/kisup.2012.64","volume":"3","author":"Kidney Disease: Improving Global Outcomes (KDIGO)","year":"2013","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO). KDIGO Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl 2013; 3: 19\u2013119.","journal-title":"Kidney Int Suppl"},{"key":"BFhr2015106_CR2","doi-asserted-by":"crossref","unstructured":"The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014). Hypertens Res 2014; 37: 253\u2013392.","DOI":"10.1038\/hr.2014.20"},{"key":"BFhr2015106_CR3","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1038\/ki.2008.102","volume":"73","author":"GL Bakris","year":"2008","unstructured":"Bakris GL, Toto RD, McCullough PA, Rocha R, Purkayastha D, Davis P,, GUARD (Gauging Albuminuria Reduction With Lotrel in Diabetic Patients With Hypertension) Study Investigators. Effects of different ACE inhibitor combinations on albuminuria: results of the GUARD study. Kidney Int 2008; 73: 1303\u20131309.","journal-title":"Kidney Int"},{"key":"BFhr2015106_CR4","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/S0140-6736(09)62100-0","volume":"375","author":"GL Bakris","year":"2010","unstructured":"Bakris GL, Sarafidis PA, Weir MR, Dahl\u00f6f B, Pitt B, Jamerson K, Velazquez EJ, Staikos-Byrne L, Kelly RY, Shi V, Chiang YT, Weber MA,, ACCOMPLISH Trial investigators. Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomized controlled trial. Lancet 2010; 375: 1173\u20131181.","journal-title":"Lancet"},{"key":"BFhr2015106_CR5","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/ki.2012.326","volume":"83","author":"S Kim-Mitsuyama","year":"2013","unstructured":"Kim-Mitsuyama S, Ogawa H, Matsui K, Jinnouchi T, Jinnouchi H, Arakawa K . An angiotensin II receptor blocker-calcium channel blocker combination prevents cardiovascular events in elderly high-risk hypertensive patients with chronic kidney disease better than high-dose angiotensin II receptor blockade alone. Kidney Int 2013; 83: 167\u2013176.","journal-title":"Kidney Int"},{"key":"BFhr2015106_CR6","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/hr.2013.100","volume":"36","author":"S Umemoto","year":"2013","unstructured":"Umemoto S, Ogihara T, Rakugi H, Matsumoto M, Kitagawa K, Shimada K, Higaki J, Ito S, Suzuki H, Ohashi Y, Saruta T, Matsuzaki M,, Combination Therapy of Hypertension to Prevent Cardiovascular. Effects of a benidipine-based combination therapy on the risk of stroke according to stroke subtype: the COPE trial. Hypertens Res 2013; 36: 1088\u20131095.","journal-title":"Hypertens Res"},{"key":"BFhr2015106_CR7","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/hr.2013.63","volume":"36","author":"H Rakugi","year":"2013","unstructured":"Rakugi H, Ogihara T, Umemoto S, Matsuzaki M, Matsuoka H, Shimada K, Higaki J, Ito S, Kamiya A, Suzuki H, Ohashi Y, Shimamoto K, Saruta T,, Combination Therapy of Hypertension to Prevent Cardiovascular Events Trial Group. Combination therapy for hypertension in patients with CKD: a subanalysis of the Combination Therapy of Hypertension to Prevent Cardiovascular Events trial. Hypertens Res 2013; 36: 947\u2013958.","journal-title":"Hypertens Res"},{"key":"BFhr2015106_CR8","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1161\/01.RES.0000256155.31133.49","volume":"100","author":"K Hayashi","year":"2007","unstructured":"Hayashi K, Wakino S, Sugano N, Ozawa Y, Homma K, Saruta T . Ca2+ channel subtypes and pharmacology in the kidney. Circ Res 2007; 100: 342\u2013353.","journal-title":"Circ Res"},{"key":"BFhr2015106_CR9","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/hr.2015.69","volume":"38","author":"N Thamcharoen","year":"2015","unstructured":"Thamcharoen N, Susantitaphong P, Wongrakpanich S, Chongsathidkiet P, Tantrachoti P, Pitukweerakul S, Avihingsanon Y, Praditpornsilpa K, Jaber BL, Eiam-Ong S . Effect of N- and T-type calcium channel blocker on proteinuria, blood pressure and kidney function in hypertensive patients: a meta-analysis. Hypertens Res 2015; 38: 847\u2013855.","journal-title":"Hypertens Res"},{"key":"BFhr2015106_CR10","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1038\/hr.2010.162","volume":"33","author":"K Hayashi","year":"2010","unstructured":"Hayashi K, Saruta T, Goto Y, Ishii M,, JATOS Study Group. Impact of renal function on cardiovascular events in elderly hypertensive patients treated with efonidipine. Hypertens Res 2010; 33: 1211\u20131220.","journal-title":"Hypertens Res"},{"key":"BFhr2015106_CR11","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/nrneph.2015.38","volume":"11","author":"M Abe","year":"2015","unstructured":"Abe M, Kalantar-Zadeh K . Haemodialysis-induced hypoglycaemia and glycaemic disarrays. Nat Rev Nephrol 2015; 11: 302\u2013313.","journal-title":"Nat Rev Nephrol"},{"key":"BFhr2015106_CR12","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1093\/ndt\/gfg263","volume":"18","author":"S Arima","year":"2003","unstructured":"Arima S, Ito S . The mechanisms underlying altered vascular resistance of glomerular afferent and efferent arterioles in diabetic nephropathy. Nephrol Dial Transplant 2003; 18: 1966\u20131969.","journal-title":"Nephrol Dial Transplant"},{"key":"BFhr2015106_CR13","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1042\/cs0560203","volume":"56","author":"S Azar","year":"1979","unstructured":"Azar S, Johnson MA, Scheinman J, Bruno L, Tobian L . Regulation of glomerular capillary pressure and filtration in young Kyoto hypertensive rats. Clin Sci 1979; 56: 203\u2013209.","journal-title":"Clin Sci"},{"key":"BFhr2015106_CR14","first-page":"F85","volume":"241","author":"TH Hostetter","year":"1981","unstructured":"Hostetter TH, Oslon JL, Rennke HG, Venkatachalam MA, Brenner BM . Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. Am J Physiol 1981; 241: F85\u2013F93.","journal-title":"Am J Physiol"},{"key":"BFhr2015106_CR15","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1056\/NEJM198207223070403","volume":"307","author":"BM Brenner","year":"1982","unstructured":"Brenner BM, Meyer TW, Hostetter TH . Dietary protein intake and the progression of kidney disease. The role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerulosclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med 1982; 307: 652\u2013659.","journal-title":"N Engl J Med"},{"key":"BFhr2015106_CR16","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/j.1755-5922.2009.00079.x","volume":"27","author":"A Takahata","year":"2009","unstructured":"Takahata A . Cilnidipine: a new generation Ca2+ channel blocker with inhibitory action on sympathetic neurotransmitter release. Cardiovasc Ther 2009; 27: 124\u2013139.","journal-title":"Cardiovasc Ther"},{"key":"BFhr2015106_CR17","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/hr.2014.136","volume":"38","author":"K Nagasawa","year":"2015","unstructured":"Nagasawa K, Takahashi K, Matsuura N, Takatsu M, Hattori T, Watanabe S, Harada E, Niinuma K, Murohara T, Nagata K . Comparative effects of valsartan in combination with cilnidipine or amlodipine on cardiac remodeling and diastolic dysfunction in Dahl salt-sensitive rats. Hypertens Res 2015; 38: 39\u201347.","journal-title":"Hypertens Res"},{"key":"BFhr2015106_CR18","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/hr.2010.221","volume":"34","author":"M Abe","year":"2011","unstructured":"Abe M, Okada K, Maruyama N, Matsumoto S, Maruyama T, Fujita T, Matsumoto K, Soma M . Benidipine reduces albuminuria and plasma aldosterone in mild-to-moderate stage chronic kidney disease with albuminuria. Hypertens Res 2011; 34: 268\u2013273.","journal-title":"Hypertens Res"},{"key":"BFhr2015106_CR19","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1038\/hr.2011.67","volume":"34","author":"M Abe","year":"2011","unstructured":"Abe M, Maruyama N, Okada K, Matsumoto S, Matsumoto K, Soma M . Additive anti-oxidative effects of azelnidipine on angiotensin receptor blocker olmesartan treatment for type 2 diabetic patients with albuminuria. Hypertens Res 2011; 34: 935\u2013941.","journal-title":"Hypertens Res"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/hr2015106.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/hr2015106","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/hr2015106.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:14:51Z","timestamp":1684430091000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/hr2015106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,1]]},"references-count":19,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["BFhr2015106"],"URL":"https:\/\/doi.org\/10.1038\/hr.2015.106","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,1]]},"assertion":[{"value":"1 October 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}